Jane Street’s Array Biopharma Inc ARRY Stock Holding History

Jane Street’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-33,500	Closed	-$1.55M	–	6170
2019 Q2	$1.55M	Sell	33,500 -8,800	-21%	-$247K	﹤0.01%	2156
2019 Q1	$1.03M	Buy	+42,300	New	+$881K	﹤0.01%	2766
2018 Q4	–	Sell	-11,200	Closed	-$170K	–	6156
2018 Q3	$170K	Sell	11,200 -58,800	-84%	-$901K	﹤0.01%	4742
2018 Q2	$1.18M	Buy	70,000 +58,300	+498%	+$927K	﹤0.01%	2547
2018 Q1	$191K	Sell	11,700 -169,800	-94%	-$2.72M	﹤0.01%	4478
2017 Q4	$2.32M	Buy	181,500 +160,000	+744%	+$1.82M	0.01%	1455
2017 Q3	$264K	Buy	+21,500	New	+$200K	﹤0.01%	3837
2017 Q2	–	Sell	-16,700	Closed	-$149K	–	5143
2017 Q1	$149K	Buy	+16,700	New	+$178K	﹤0.01%	3926
2016 Q4	–	Sell	-73,000	Closed	-$493K	–	4865
2016 Q3	$493K	Buy	+73,000	New	+$282K	﹤0.01%	2787
2016 Q1	–	Sell	-12,800	Closed	-$54K	–	4880
2015 Q4	$54K	Buy	+12,800	New	+$58.4K	﹤0.01%	3869

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Jane Street's ARRY Position: Q3 2019 in Review

Jane Street sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 54,982 shares — an estimated $2.55M sold.

Jane Street first reported a position in ARRY in Q2 2014 and held it in 14 quarters. The position peaked at $2.82M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Jane Street reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Jane Street sold 54,982 Array Biopharma Inc shares in Q3 2019, an estimated $2.55M.
Jane Street first reported a position in Array Biopharma Inc in Q2 2014 and held it in 14 quarters.
Jane Street's Array Biopharma Inc position peaked at $2.82M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.